[ad_1]
Six people died during vaccine trials, jointly developed by the American pharmaceutical company Pfizer and the German biotechnology company BioNTech. This is stated in a document posted on the United States Food and Drug Administration (FDA) website.
“There were six deaths during the reporting period (two deaths in the vaccinated group and four in the placebo group), “states in a document prepared for an FDA meeting, which is scheduled for Thursday.
Updated
In the United States with prior approval of the Pfizer / BioNtech vaccine
The US agency is expected to make a final decision on the vaccine in a few days.
It is observed that in the group that received the vaccine, one one participant with atherosclerosis and obesity died three days after the first dose preparation, and another participant suffered cardiac arrest 60 days after the second dose and three days later his death was registered.
In the placebo group two people died of stroke and heart attack, since the cause of death of two more participants has not been established. Half of the deaths in all groups were older than 55 years.
The FDA has scheduled a meeting for December 10 for approval of the vaccine developed by Pfizer and BioNTech. The companies submitted the corresponding application to the administration on November 20. Previously, it was reported that US authorities hope to begin vaccinating people against the coronavirus on December 11 or 12.
90-year-old British woman is the first in the world to be vaccinated against COVID-19 with Pfizer / BioNTech
Today, the UK is launching its largest immunization program.
[ad_2]
